课题基金 / 基金详情

Synthesis of Polymeric AIDS Dryg with Lasting Activity

Synthesis of Polymeric AIDS Dryg with Lasting Activity
具有持久活性的高分子助剂的合成
批准号:
01850199
负责人:
URYU Toshiyuki
金额:
$7.55万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991

项目摘要

项目成果

URYU Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
合成的核糖呋喃、木氯呋喃、葡聚糖硫酸盐等多糖不仅具有较高的抗艾滋病病毒活性,而且具有较高的抗凝血活性,这被认为是副作用。本研究首次合成了具有高抗hiv活性但低抗凝血活性的硫酸酸化多糖。以1,3 - β -连接的香菇多糖为研究对象,用哌啶n -磺酸对香菇多糖进行硫酸酸化,得到硫酸香菇多糖。硫酸香菇多糖具有较高的抗hiv活性,体外浓度低至3.3马克杯/毫升,可完全抑制艾滋病病毒对T淋巴细胞的感染。其抗凝血活性较低,约为20单位/mg。然后,采用相同的方法对具有与香菇多糖相同骨架结构的细菌多糖凝乳酶进行硫酸酸化,得到硫酸凝乳酶。硫酸铁多糖具有较高的抗hiv活性,浓度为3.3马克杯/毫升时可抑制病毒感染,抗凝血活性较低,为15单位/毫克。引入动物血液中的硫酸凝乳素被输送到肝脏、肾脏、淋巴结、骨髓等组织,注射后60-180分钟从血液中消失。为了使血液中硫酸凝乳素的浓度长时间保持在较高水平,将l -葡萄糖、l -甘露糖等非天然糖与凝乳素和合成的核糖呋喃反应形成l -糖基分支。l-糖基支链硫酸多糖在血液中抗凝血活性的体内保留时间为几小时。结果表明,吸收的硫酸凝乳素在组织中存在数天而不受主链降解。合成的1,6 - α - d -甘露聚糖硫酸酯具有较高的抗hiv活性和中等的抗凝血活性。
英文摘要
Such synthetic polysaccharides as ribofuranan, xylofuranan, and dextran sulfates showed not only high anti-AIDS virus (anti-HIV) activity, but also high anticoagulant activity which is assumed to be side effects. In this study, sulfated polysaccharides with high anti-HIV activity but low anticoagulant activity were for the first time synthesized. A 1, 3-beta-linked antitumor polysaccharide lentinan was sulfated with piperidine N-sulfonic acid to afford lentinan sulfate. Lentinan sulfate had high anti-HIV activity inhibiting completely AIDS virus infection to T lymphocytes in a concentration as low as 3.3 mug/ml in vitro. Moreover, it showed low anticoagulant activity of about 20 unit/mg. Next, a bacterial polysaccharide curdlan having the same backbone structure as lentinan was sulfated by the same method to give curdlan sulfate. Curdlan sulfate had a high anti-HIV activity which inhibits the virus infection in a a 3.3 mug/ml concentration, and showed low anticoagulant activity of 15 unit/mg. The curdlan sulfate introduced into animal blood was transported into such tissues as liver, kidney, lymph node, and bone marrow, disappearing from the blood in 60-180 minutes after injection. To keep the concentration of curdlan sulfate in blood in a high level for longer time, such nonnatural sugars as L-glucose and L-mannose were reacted with curdlan and syntheric ribofuranan to form L-glycosyl branchings. For L-glyscosyl-branched polysaccharide sulfates, in vivo retention time of the anticoagulant activity in blood was a few hours. It was revealed that the absorbed curdlan sulfate exisis in the tissue for a few ten days without being subjected to main chain degradation. Syntheric 1, 6-alpha-D-mannan sulfate had high anti-HIV activity and medium anticoagulant activity.
期刊论文(100)
专著(0)
科研奖励(0)
会议论文
Y.Kaneko et al.: "Complete Inhibition of HIV-1 Infectivity With Curdlan Sulfate in Vitro" Biochem.Pharm.39. 793-797 (1990)
Y.Kaneko 等人:“硫酸凝胶多糖在体外完全抑制 HIV-1 感染”Biochem.Pharm.39。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Hatanaka et al.: "Synthesis and Sulfation of Branched Dextrans" Polym.J.22. 435-441 (1990)
K.Hatanaka 等人:“支链葡聚糖的合成和硫酸化”Polym.J.22。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Uryu et al.: "Sulfated Alkyl Oligosaccharides with Porent Inhibitory Effects on Human Immunodeficiency Virus Infection" Biochem.Pharm.
T.Uryu 等人:“硫酸烷基寡糖对人类免疫缺陷病毒感染具有有效的抑制作用”Biochem.Pharm。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
瓜生 敏之,吉田 孝: "「バイオ新素作」本宮 達也,松永 是編著" 日刊工業新聞社, 15 (1990)
Toshiyuki Uryu、Takashi Yoshida:“New Bio Draft”,由 Tatsuya Motomiya 和 Kore Matsunaga 编辑,日刊工业新闻,15(1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 48 条
    Synthesis of Dendrimer-Type AIDS Vaccine having Cyclic Peptide Antigen
    Synthesis of Dendrimer-Type AIDS Vaccine Having High Antibody Productivity
    Super-Biosystem Constructed by Cognitive Multidimensional Glyco-Molecules
    Activation of Biofunctional Molecules Induced by Binding of Glycomolecules
    • 批准号:
      08455435
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.35万
    • 财政年份:
      1996
    • 负责人:
      URYU Toshiyuki
    • 依托单位:
    海外基金